References
- Marsigliante S, Leo G, Resta L, Storelli C. Steroid receptor status in malignant and non-malignant larynx. Ann Oncol 1992; 3: 387–92
- Virolainen E, Tuohimaa P, Aitasalo K. Steroid hormone receptors in laryngeal carcinoma. Otolaryngol Head Neck Surg 1986; 94: 512–7
- Ferguson B J, Hudson W R, McCarty J RKS. Sex steroid receptor distribution in human larynx and laryngeal carcinoma. Arch Otolaryngol 1987; 113: 1311–5
- Shapira A, Virolainem E, Jameson J J, Ossakow V, Carey T E. Growth inhibition of laryngeal UM-SCC cell line by tamoxifen. Arch Otolaryngol Head Neck Surg 1986; 112: 1158
- Von Maillot K, Weidenbecher M, Gentsch H H. Advanced larynx cancer, steroid receptor and hormonal treatment. Cancer Treat Rep 1979; 63: 1195
- Reiner Z, Curtila D, Petric V. Cytoplasmic steroid receptors in cancer of the larynx. Arch Otorhinolaryngo1 1988; 245: 47–9
- Mattox E, Von Hoff D, McGuire W. Androgen receptors and antiandrogen therapy for laryngeal carcinoma. Arch Otolaryngol 1984; 110: 721–4
- Sherman M R, Pickering L A, Rollwagen F M, Miller L K. Meroreceptors: proteolitic fragments of receptors containing the steroid binding site. Fed Proc 1978; 37: 167
- Rusconi S, Yamamoto K R. Functional dissection of the hormone binding and DNA binding activities of the glucocorticoid receptors. EMBO 1987; 6: 1309–15
- Marsigliante S, Muscella A, Resta L, Storelli C. Human larynx expresses isoforms of the oestrogen receptor. Cancer Lett 1996; 99: 191–6
- Resta L, Fiorella R, Marsigliante S, et al. Stato recetto-riale del carcinoma laringeo: studio dei recettori per estrogeni, progesterone, androgeni e glucocorticoidi. Acta Otorhinol Ital 1994; 14: 385–92
- Coffer A I, Lewis K M, Brockas A J, King R JB. Monoclonal antibodies against a component related to soluble estrogen receptor. Cancer Res 1985; 45: 3686–96
- King R JB, Coffer A I, Gilbert J, et al. Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium. Cancer Res 1985; 45: 5728–33
- Cano A, Coffer A I, Adatia R, Millis R R, Rubens R S, King R BJ. Histochemical studies with an estrogen receptor related protein in human breast tumors. Cancer Res 1986; 46: 6475–80
- Almadori G, Cadoni G, Maurizi M, et al. Oncogeni e cancro del laringe. EGFR, p21 ras ed infezioni da HPV-DNA. Acta Otorhinol Ital 1995; Suppl 46: 1–23
- Perez R, Pascual M, Macias A, Lage A. Epidermal growth factors receptors in human breast cancer. Breast Cancer Res Treat 1984; 4: 189–93
- Sainsbury J RC, Malcom A J, Appleton D R, Farndon J R, Harris A L. Presence of epidermal growth factor receptor as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 1985; 38: 1225–8
- Spyratros F, Brouillet J P, Defrenne A, et al. Cathepsin D: an indipendent prognostic factor for metastasis of breast cancer. Lancet 1989; ii: 1115–8
- Touitou I, Cavailles V, Garcia M, Defrenne A, Roche-Fort H. Differential regulation of cathepsin D by sex steroids in mammary cancer and uterine cells. Mol Cell Endocrinol 1989; 66: 231–8
- Marsigliante S, Resta L, Leo G, Mazzotta D, d'Amore R, Biscozzo L, Storelli C. Expression of cathepsin D in malignant and in the corresponding non-malignant node-negative laryngeal samples: correlation with receptors for androgen, glucocorticoid, oestrogen and progesterone. Cancer Lett 1993; 68: 135–42
- Marsigliante S, Biscozzo L, Resta L, et al. Immunohis-tochemical and immunoradiometric evaluations of total cathepsin D in human larynx. Eur J Cancer 1994; 30B: 51–5
- Resta L, Fiorella R, Di Nicola V, Marzullo A, Botticella M A, Maiorano E. Cathepsin D in laryngeal carcinoma. Preliminary report. J Biol Res—Boll SOC Ital Biol Sper 1995; 71: 257–61
- Zeillinger R, Swoboda H, Machacek E, et al. Expression of cathepsin D in head and neck cancer. Eur J Cancer 1992; 28A: 1413–5
- Marsigliante S, Resta L, Muscella A, Vinson G P, Marzullo A, Storelli C. AT1 Angiotensin II receptor subtype in the human larynx and squamous laryngeal carcinoma. Cancer Lett (in press)
- Huckle W R, Earp H S. Regulation of cell proliferation and growth by angiotensin II. Prog Growth Factor Res 1994; 5: 177–94